Background: Mesenchymal stem cells (MSCs) derived from bone marrow (BM-MSCs) and adipose tissue (AT-MSCs) are being applied to equine cell therapy. The physiological environment in which MSCs reside is hypoxic and does not resemble the oxygen level typically used in in vitro culture (20% O2). This work compares the growth kinetics, viability, cell cycle, phenotype and expression of pluripotency markers in both equine BM-MSCs and AT-MSCs at 5% and 20% O2.

Results: At the conclusion of culture, fewer BM-MSCs were obtained in hypoxia than in normoxia as a result of significantly reduced cell division. Hypoxic AT-MSCs proliferated less than normoxic AT-MSCs because of a significantly higher presence of non-viable cells during culture. Flow cytometry analysis revealed that the immunophenotype of both MSCs was maintained in both oxygen conditions. Gene expression analysis using RT-qPCR showed that statistically significant differences were only found for CD49d in BM-MSCs and CD44 in AT-MSCs. Similar gene expression patterns were observed at both 5% and 20% O2 for the remaining surface markers. Equine MSCs expressed the embryonic markers NANOG, OCT4 and SOX2 in both oxygen conditions. Additionally, hypoxic cells tended to display higher expression, which might indicate that hypoxia retains equine MSCs in an undifferentiated state.

Conclusions: Hypoxia attenuates the proliferative capacity of equine MSCs, but does not affect the phenotype and seems to keep them more undifferentiated than normoxic MSCs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483288PMC
http://dx.doi.org/10.1186/1746-6148-8-142DOI Listing

Publication Analysis

Top Keywords

equine mscs
12
mesenchymal stem
8
stem cells
8
derived bone
8
bone marrow
8
adipose tissue
8
markers equine
8
oxygen conditions
8
gene expression
8
mscs
7

Similar Publications

Synovitis is present before and during osteoarthritis in horses and can result in performance-limiting lameness. Twenty-four horses with lameness localized to the metacarpo-/metatarsophalangeal joint or a single joint of the carpus were enrolled in this study. We evaluated the response of intra-articular injection with 10 million activated (aMSC) or non-activated (naMSC) allogeneic equine umbilical cord blood-derived mesenchymal stromal cells (MSCs).

View Article and Find Full Text PDF
Article Synopsis
  • Intercellular mitochondrial transfer from mesenchymal stromal cells (MSCs) to chondrocytes may enhance tissue healing and has potential for treating osteoarthritis, but the mechanisms are not fully understood.
  • The study aimed to investigate the role of connexin 43 (Cx43) in this transfer, especially under oxidative stress conditions, and tested hypotheses about increased mitochondrial transfer and the influence of Cx43 expression.
  • Results indicated that oxidative stress in chondrocytes promoted mitochondrial transfer from MSCs, which was significantly enhanced by direct cell contact, with evidence showing Cx43 localizing at these contact sites.
View Article and Find Full Text PDF
Article Synopsis
  • MSC therapy shows strong promise for treating various eye conditions in animals, including corneal ulcers and retinal degeneration, by utilizing the healing properties of mesenchymal stem cells (MSCs).
  • Research indicates that MSCs can reduce inflammation, promote tissue regeneration, and improve clinical outcomes in veterinary patients experiencing ocular diseases.
  • Effective delivery methods like injections and tissue engineering are key to maximizing MSC therapy's benefits, with ongoing studies aimed at overcoming challenges and enhancing long-term safety for future applications.
View Article and Find Full Text PDF

Impact of different formulations of platelet lysate on proliferative and immune profile of equine mesenchymal stromal cells.

Front Vet Sci

August 2024

Unidad de Inmunología e Inmunoterapia, Departamento de Patobiología, Facultad de Veterinaria, Universidad de la República, Montevideo, Uruguay.

Platelet lysate (PL) is investigated as a potential replacement for fetal bovine serum (FBS) in cell culture. However, there is limited research on its impact on the immune profile of equine mesenchymal stromal cells (eMSCs). This study aimed to evaluate the effects of different PL formulations on the proliferative capacity, multipotentiality, and immune profile of equine adipose tissue-derived MSCs (eAD-MSCs).

View Article and Find Full Text PDF

Artificial mitochondrial transplantation (AMT) reverses aging of mesenchymal stromal cells and improves their immunomodulatory properties in LPS-induced synoviocytes inflammation.

Biochim Biophys Acta Mol Cell Res

October 2024

Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Norwida 27B, 50-375 Wroclaw, Poland; Department of Veterinary Medicine and Epidemiology, Veterinary Institute for Regenerative Cures, School of Veterinary Medicine, University of California, Davis, CA 95516, United States. Electronic address:

Nowadays, regenerative medicine techniques are usually based on the application of mesenchymal stromal cells (MSCs) for the repair or restoration of injured damaged tissues. However, the effectiveness of autologous therapy is limited as therapeutic potential of MSCs declines due to patient's age, health condition and prolonged in vitro cultivation as a result of decreased growth rate. For that reason, there is an urgent need to develop strategies enabling the in vitro rejuvenation of MSCs prior transplantation in order to enhance their in vivo therapeutic efficiency.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!